- Country: Czech Republic
- Summary: Drugs for Nemcb (062025) - L01fc01 Daratumumab
- CZT Ref No: 115509088
- Deadline: 31 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 8662000
- Notice Type: Tender
- Document Ref. No.: 135274-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public contract is the continuous supply of medicinal products according to the ATC Group L01FC01 Daratumumumab in accordance with the valid legislation for 48 months.
Drugs for Nemcb (062025) - L01FC01 Daratumumab
Continuous supplies of medicinal products according to ATC L01FF02 Pembrolizumab for Czech Hospital - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDrugs for Nemcb (062025) - L01fc01 Daratumumab - Czech Republic Tender
The HOSPITAL ČESKE BUDĚJOVICE, A.S., a Government sector organization in Czech Republic, has announced a new tender for Drugs for Nemcb (062025) - L01fc01 Daratumumab. This tender is published on CzechRepublicTenders under CZT Ref No: 115509088 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-31.
The estimated tender value is CZK 8662000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
